The effects of free amino acids profiles on seeds germination/dormancy and seedlings development of two genetically different cultivars of Yemeni Pomegranates

Plant seeds used rely on a wide range of internal mechanisms and physio-chemical factors to ensure their germination under favorable environmental conditions. Most plant seeds have complex process of germination, including water, oxygen, temperature availability, genome-wide gene expression, signal transduction, hormones stimulations, inhibitors removal and catalytic protein synthesis. In addition, influences of seeds nutrient values such as, protein, lipids, sugars and free amino acids have a special importance. Regarding, seeds free amino acids. Discussion of these individual factors needs to be put in context of their role in germination processes. Regarding, free amino acids seed storage, there is limited information about their relevant functions in activation and/or deactivation of required metabolic mechanisms and interactive compounds involved in this process in commercial plant cultivars. Therefore, current study was aimed to determine the probable influence of free amino acid compositions of seeds on germination process of two different (Punica granatum L.) pomegranate cultivars including wild type Automi cultivar and edible Khazemi cultivar. In particular, we focused on the impact of amino acids contents variations on germination process and associated AAs compositional changes during various stages of germination and seedlings establishment. Amino acid analysis using HPLC detected all the essential and non-essential amino acids in the raw seeds of the studied cultivars, Automi and Khazemi along with AAs compositional changes occurred during different stages of seed germination. These AAs have been extensively analyzed in the context of their role in dormancy breaking capacities in plants species. Automi raw seeds are rich in Phe, that, is strongly related to ABA synthesis and hence might be responsible for the dormancy of Automi seeds, Khazemi raw seeds have sufficient levels of Arg, Glu and Met that have been reported to enhance seeds germination in plant, therefore Khazemi germination capacity was assumed to be regulated more or less by these AAs. In addition, changes in amino acid composition in the germinated Khazemi cultivar during various stages of seeds germination including imbibition, germination, and sprouts stages have been noticed to change in response with germination demands. This suggests that amino acids reserves in dry seeds are major determinant for germination capacity and germination behavior in the following steps of germination. The noticed particular AAs increase/decrease along the time course of Khazemi pomegranate germination till establishment of heterotrophic seedlings were used as cornerstones for elucidation and deduction of putative function and relevant biochemical pathways controlling initiation of seeds germination and seedlings developments. Based on publicly available databases of model plants and literatures surveys, we established correlations between prevailing AAs factors as biochemical parameters actively involved in seeds dormancy-breaking and germination process

Precision neutron interferometric measurements of the n-p, n-d, and n-3He zero-energy coherent neutron scattering amplitudes

We have performed high precision measurements of the zero-energy neutron scattering amplitudes of gas phase molecular hydrogen, deuterium, and $^{3}$He using neutron interferometry. We find $b_{\mathit{np}}=(-3.7384 \pm 0.0020)$ fm\cite{Schoen03}, $b_{\mathit{nd}}=(6.6649 \pm 0.0040)$ fm\cite{Black03,Schoen03}, and $b_{n^{3}\textrm{He}} = (5.8572 \pm 0.0072)$ fm\cite{Huffman04}. When combined with the previous world data, properly corrected for small multiple scattering, radiative corrections, and local field effects from the theory of neutron optics and combined by the prescriptions of the Particle Data Group, the zero-energy scattering amplitudes are: $b_{\mathit{np}}=(-3.7389 \pm 0.0010)$ fm, $b_{\mathit{nd}}=(6.6683 \pm 0.0030)$ fm, and $b_{n^{3}\textrm{He}} = (5.853 \pm .007)$ fm. The precision of these measurements is now high enough to severely constrain NN few-body models. The n-d and n-$^{3}$He coherent neutron scattering amplitudes are both now in disagreement with the best current theories. The new values can be used as input for precision calculations of few body processes. This precision data is sensitive to small effects such as nuclear three-body forces, charge-symmetry breaking in the strong interaction, and residual electromagnetic effects not yet fully included in current models.Comment: 6 pages, 4 figures, submitted to Physica B as part of the Festschrift honouring Samuel A. Werner at the International Conference on Neutron Scattering 200

ISSR markers for analysis of molecular diversity and genetic structure of Indian teak (Tectona grandis L.f.) populations

Inter simple sequence repeats (ISSR) constitute a powerful dominantDNA molecular marker system used for diversity analysis, which isindispensable for making estimates of genetic base and demarcation of populations for undertaking conservation and improvement program of forest tree species. Twenty nine populations of teak (Tectona grandis L.f.) were collected from central and peninsular India for analysis of genetic diversity and structure. Genomic DNA from ten randomly selected individuals of each population was extracted and amplified using five ISSR primers(UBC-801, 834, 880, 899 and 900). The primers showed 100% polymorphism. UBC-900 recorded the highest Nei’s genetic diversity (0.32 to 0.40)and UBC-899 had the highest Shannon’s Information Index (0.49 to 0.59). AMOVA revealed a very high intra-population genetic diversity (91%), in comparison to inter-population genetic diversity among states (6.17%) and within states (2.77%) which were also indirectly confirmed by large standard deviations associated with genetic diversity estimates for individual population, as well as poor bootstrapping values for most of the cluster nodes. However, UPGMA dendrogram revealed several clusters, with populationsfrom central India being present almost in each cluster, makinggroups with populations of adjoining states and distant states. Nevertheless,the cluster analysis distinguished the drier teak populations of central India from the moist teak populations of south India, which was also confirmed by Principle Coordinate Analysis. The findings advocates the need not only for enhancing selection intensity for large number of plus trees, but also for laying out more number of in situ conservation plots within natural populations of each cluster for germplasm conservation of teak aimed at improving the teak productivity and quality in future

A STUDY ON SEROPREVELENCE AND RISK FACTORS OF BOVINE LEPTOSPIROSIS IN LOWER ASSAM, INDIA

The present study was conducted to ascertain the seroprevalence of Leptospira infection in cattle among certain districts of the lower Brahmaputra valley in the state of Assam from March 2017 to February 2018. Two serological tests viz. IgG ELISA and Microscopic Agglutination Test (MAT) were used to detect the leptospiral antibodies. The anti-leptospiral antibodies were detected by IgG ELISA and compared with MAT using antigens from 12 pathogenic serovars. Out of 380 sera samples, 68 (17.89 %, 95% CI: 6.89-27) and 44 (11.58%) were positive by IgG ELISA and MAT respectively. The circulating Leptospira serovars identified were Autumnalis (6.05%), Ballum (2.63%), Batavia (1.31%), Ichterohaemorrhagie (0.7%), Javanica (0.5%) and Sejroe (0.2%). The sensitivity and specificity of IgG ELISA in comparison to MAT were calculated and found to be 100% and 92.85% respectively with a concordance of 93.68%. An epidemiological investigation was carried out to find the association of various risk factors with Leptospira infection under this study in cattle using a pre-tested questionnaire. The present study will serve as baseline data for the prevention and control of Leptospira infection in cattle

Flow of foam through a convergent channel

International audienceWe study experimentally the flow of a foam confined as a bubble monolayer between two plates through a convergent channel. We quantify the velocity, the distribution and orientation of plastic events, and the elastic stress, using image analysis. We use two different soap solutions: a sodium dodecyl sulfate (SDS) solution, with a negligible wall friction between the bubbles and the confining plates, and a mixture containing a fatty acid, giving a large wall friction. We show that for SDS solutions, the velocity profile obeys a self-similar form which results from the superposition of plastic events, and the elastic deformation is uniform. For the other solution, the velocity field differs and the elastic deformation increases towards the exit of the channel. We discuss and quantify the role of wall friction on the velocity profile, the elastic deformation, and the rate of plastic events

Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease

The development, homeostasis, and repair of intrahepatic and extrahepatic bile ducts are thought to involve distinct mechanisms including proliferation and maturation of cholangiocyte and progenitor cells. This study aimed to characterize human extrahepatic cholangiocyte organoids (ECO) using canonical Wnt-stimulated culture medium previously developed for intrahepatic cholangiocyte organoids (ICO). Paired ECO and ICO were derived from common bile duct and liver tissue, respectively. Characterization showed both organoid types were highly similar, though some differences in size and gene expression were observed. Both ECO and ICO have cholangiocyte fate differentiation capacity. However, unlike ICO, ECO lack the potential for differentiation towards a hepatocyte-like fate. Importantly, ECO derived from a cystic fibrosis patient showed n

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Background: Oral semaglutide is the first oral formulation of a glucagon-like peptide-1 (GLP-1) receptor agonist developed for the treatment of type 2 diabetes. We aimed to compare the efficacy and safety of flexible dose adjustments of oral semaglutide with sitagliptin 100 mg. Methods: In this 52-week, multicentre, randomised, open-label, phase 3a trial, we recruited patients with type 2 diabetes from 81 sites in ten countries. Patients were eligible if they were aged 18 years or older (19 years or older in South Korea), had type 2 diabetes (diagnosed ≥90 days before screening), HbA1c of 7·5–9·5% (58–80 mmol/mol), and were inadequately controlled on stable daily doses of one or two oral glucose-lowering drugs (for 90 days or more before screening). Participants were randomly assigned (1:1) by use of an interactive web-response system, stratified by background glucose-lowering medication at screening, to oral semaglutide with flexible dose adjustments to 3, 7, or 14 mg once daily or sitagliptin 100 mg once daily. To approximate treatment individualisation in clinical practice, oral semaglutide dose could be adjusted on the basis of prespecified HbA1c and tolerability criteria. Two efficacy-related estimands were prespecified: treatment policy (regardless of treatment discontinuation or use of rescue medication) and trial product (on treatment and without use of rescue medication) for participants randomly assigned to treatment. The primary endpoint was achievement of HbA1c of less than 7% (53 mmol/mol) at week 52 and the confirmatory secondary efficacy endpoint was change in bodyweight from baseline to week 52. Safety was assessed in all participants who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT02849080, and European Clinical Trials Database, EudraCT number 2015-005593-38, and an open-label extension is ongoing. Findings: Between Sept 20, 2016, and Feb 7, 2017, of 804 patients assessed for eligibility, 504 were eligible and randomly assigned to oral semaglutide (n=253) or sitagliptin (n=251). Most participants were male (285 [57%] of 504) with a mean age of 57·4 years (SD 9·9). All participants were given at least one dose of their allocated study drug except for one participant in the sitagliptin group. From a mean baseline HbA1c of 8·3% (SD 0·6%; 67 mmol/mol [SD 6·4]), a greater proportion of participants achieved an HbA1c of less than 7% with oral semaglutide than did with sitagliptin (treatment policy estimand: 58% [134 of 230] vs 25% [60 of 238]; and trial product estimand: 63% [123 of 196] vs 28% [52 of 184]). The odds of achieving an HbA1c of less than 7% was significantly better with oral semaglutide than sitagliptin (treatment policy estimand: odds ratio [OR] 4·40, 95% CI 2·89–6·70, p<0·0001; and trial product estimand: 5·54, 3·54–8·68, p<0·0001). The odds of decreasing mean bodyweight from baseline to week 52 were higher with oral semaglutide than with sitagliptin (estimated mean change in bodyweight, treatment policy estimand: −2·6 kg [SE 0·3] vs −0·7 kg [SE 0·2], estimated treatment difference [ETD] −1·9 kg, 95% CI −2·6 to −1·2; p<0·0001; and trial product estimand: −2·9 kg [SE 0·3] vs −0·8 kg [SE 0·3], ETD −2·2 kg, −2·9 to −1·5; p<0·0001). Adverse events occurred in 197 (78%) of 253 participants in the oral semaglutide group versus 172 (69%) of 250 in the sitagliptin group, and nausea was the most common adverse event with oral semaglutide (53 [21%]). Two deaths occurred in the sitagliptin group during the trial. Interpretation: Oral semaglutide, with flexible dose adjustment, based on efficacy and tolerability, provided superior glycaemic control and weight loss compared with sitagliptin, and with a safety profile consistent with subcutaneous GLP-1 receptor agonists. Funding: Novo Nordisk A/S